美国州级综合保险强制令对体外受精利用、胚胎移植实践及结局的影响
基于2018年美国CDC辅助生殖技术报告中的134,997个体外受精周期,回顾性队列研究比较综合强制令州与非综合强制令州的结局。综合强制令州体外受精利用率高132%,每周期活产率35.4% vs 33.4%,多胎率10.2% vs 13.8%,每移植胚胎数1.30 vs 1.36,冻胚移植占比66.1% vs 76.3%(均P<.001)。
要点
- 综合强制令州体外受精利用率较非综合强制令州高132%。
- 综合强制令州每周期活产率35.4% vs 33.4%,多胎率10.2% vs 13.8%。
- 综合强制令州每移植胚胎数1.30 vs 1.36,冻胚移植占比66.1% vs 76.3%。
核心结论
- 综合州级体外受精保险强制令与更高的体外受精利用率、更少的每移植胚胎数、更少的冻胚移植、更低的多胎率和更高的活产率相关。
研究设计与样本
- 回顾性队列研究,分析2018年美国CDC辅助生殖技术生育诊所成功率报告中的体外受精周期。
- 共纳入456家诊所的134,997个体外受精周期。
- 按州强制令状态分层:综合强制令州(对体外受精提供限制最少的覆盖)和非综合强制令州。
- 使用2018年美国人口普查估计计算各州育龄妇女人数。
- 按患者年龄组进行亚组分析。
主要发现
- 综合强制令州实施32,029个周期,非综合强制令州实施102,968个周期。
- 年龄调整后,综合强制令州体外受精利用率较非综合强制令州高132%,且各年龄层均观察到利用率升高。
- 综合强制令州每周期活产率显著高于非综合强制令州(35.4% vs 33.4%;P<.001),在较高年龄组中尤为明显。
- 综合强制令州多胎率占所有活产的比例显著低于非综合强制令州(10.2% vs 13.8%;P<.001),在较年轻患者中尤为明显。
- 综合强制令州每移植平均胚胎数显著低于非综合强制令州(1.30 vs 1.36;P<.001);冻胚移植占所有胚胎移植的比例显著更低(66.1% vs 76.3%;P<.001);新鲜胚胎移植中,综合强制令州所有患者的移植胚胎数显著更少(1.55 vs 1.67;P<.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous studies have demonstrated that state mandated coverage of in vitro fertilization may be associated with increased utilization, fewer embryos per transfer, and lower multiple birth rates, but also lower overall live birth rates. Given new legislation and the delay between enactment and effect, a revisit of this analysis is warranted. OBJECTIVE: This study aimed to characterize the current impact of comprehensive state in vitro fertilization insurance mandates on in vitro fertilization utilization, live birth rates, multiple birth rates, and embryo transfer practices. STUDY DESIGN: We conducted a retrospective cohort study of in vitro fertilization cycles reported by the 2018 Centers for Disease Control and Prevention Assisted Reproductive Technology Fertility Clinic Success Rates Report in the United States. In vitro fertilization cycles were stratified according to state mandate as follows: comprehensive (providing coverage for in vitro fertilization with minimal restrictions) and noncomprehensive. The United States census estimates for 2018 were used to calculate the number of reproductive-aged women in each state. Outcomes of interest (stratified by state mandate status) included utilization rate of in vitro fertilization per 1000 women aged 25 to 44 years, live birth rate, multiple birth rate, number of embryo transfer procedures (overall and subdivided by fresh vs frozen cycles), and percentage of transfers performed with frozen embryos. Additional subanalyzes were performed with stratification of outcomes by patient age group. RESULTS: In 2018, 134,997 in vitro fertilization cycles from 456 clinics were reported. Six states had comprehensive mandates; 32,029 and 102,968 cycles were performed in states with and without comprehensive in vitro fertilization mandates, respectively. In vitro fertilization utilization in states with comprehensive mandates was 132% higher than in noncomprehensive states after age adjustment; increased utilization was observed regardless of age stratification. Live birth rate per cycle was significantly higher in states with comprehensive mandates (35.4% vs 33.4%; P<.001), especially among older age groups. Multiple birth rate as a percentage of all births was significantly lower in states with comprehensive mandates (10.2% vs 13.8%; P<.001), especially among younger patients. Mean number of embryos per transfer was significantly lower in states with comprehensive mandates (1.30 vs 1.36; P<.001). Significantly fewer frozen transfers were performed as a percentage of all embryo transfers in states with comprehensive mandates (66.1% vs 76.3%; P<.001). Among fresh embryo transfers, significantly fewer embryos were transferred in comprehensive states among all patients (1.55 vs 1.67; P<.001). CONCLUSION: Comprehensive state mandated insurance coverage for in vitro fertilization services is associated with greater utilization of these services, fewer embryos per transfer, fewer frozen embryo transfers, lower multiple birth rates, and higher live birth rates. These findings have important public health implications for reproductive-aged individuals in the United States and present notable opportunities for research on access to fertility care.
引用
- Peipert BJ, Chung EH, Harris BS, et al. Impact of comprehensive state insurance mandates on in vitro fertilization utilization, embryo transfer practices, and outcomes in the United States. Am J Obstet Gynecol. 2022. PMID: 35283088. doi:10.1016/j.ajog.2022.03.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。